Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through ...
Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of proprietary cell-derived therapies for fibrotic diseases, and Qureight Ltd, a Core Imaging Laboratory with ...
Rentosertib is designed to treat IPF by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular processes that include signal ...
Sawyer Hawks, a Vanderbilt baseball transfer, is guided by his late mother's memory and by the community that helped raise ...
ABC7 New York on MSN5h
Long COVID survivor still fighting symptoms 5 years after start of pandemicGREENVALE, Nassau County (WABC) -- A long COVID survivor is still recovering five years after the pandemic first swept across the world.
Alongside new steps in its therapeutic pipeline—and a new push into laboratory robotics—Insilico Medicine has raised $110 ...
Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...
Nancy Wilk and her team at WSP are on a mission to drive progress on preventable illnesses in the mining sector. Integrated [ ...
Insilico Medicine Inc. is considering an initial public offering after securing funding at a valuation of more than $1 billion, reflecting growing interest in the potential use of AI to discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback